Table 2.

Systemic adverse events considered to be at least possibly related to the vaccine.

Adverse Event	Cohort A-1 (N = 5)	Cohort A-2 (N = 5)	Cohort B (N = 10)	Cohort C (N = 10)	Cohort D (N = 10)	Cohort E (N = 10)	Total (N = 50)
Abdominal Pain	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (10.0)	0 (0.0)	1 (2.0)
Arthralgia	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (10.0)	1 (10.0)	2 (4.0)
Aspartate Aminotransferase Increased	0 (0.0)	1 (20.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (2.0)
Chills	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (10.0)	0 (0.0)	1 (2.0)
Loose/Soft stools	0 (0.0)	1 (20.0)	2 (20.0)	2 (20.0)	2 (20.0)	1 (10.0)	8 (16.0)
Fatigue	0 (0.0)	0 (0.0)	1 (10.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (2.0)
Headache	1 (20.0)	0 (0.0)	1 (10.0)	1 (10.0)	2 (20.0)	0 (0.0)	5 (10.0)
Leukopenia	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (10.0)	0 (0.0)	1 (2.0)
Malaise	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	2 (20.0)	1 (10.0)	3 (6.0)
Myalgia	0 (0.0)	0 (0.0)	0 (0.0)	1 (10.0)	2 (20.0)	2 (20.0)	5 (10.0)
Nausea	0 (0.0)	0 (0.0)	0 (0.0)	1 (10.0)	1 (10.0)	0 (0.0)	2 (4.0)
Pruritus, inner arm	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (10.0)	1 (2.0)
Pyrexia	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (10.0)	0 (0.0)	1 (2.0)